USASpending / award record
MARK CUBAN COST PLUS DRUG COMPANY (MCCPDC) INTENDS TO GENERATE A CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA PACKAGE SUITABLE FOR AN FDA ABBREVIATED NEW DRUG APPLICATION (ANDA).
Source: USASpending · CONT_AWD_W911SR26CA011_9700_-NONE-_-NONE- · As of 2026-05-08 · Last synced 2026-11-10
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.
- source record id
- CONT_AWD_W911SR26CA011_9700_-NONE-_-NONE-
- generated unique award id
- CONT_AWD_W911SR26CA011_9700_-NONE-_-NONE-
- source
- USASpending
- award id piid
- W911SR26CA011
- vendor name as awarded
- MARK CUBAN COST PLUS DRUG COMPANY, PBC
- vendor uei
- N8P7MQ937WN7
- agency name
- Department of Defense
- sub agency
- Department of the Army
- contract title or description
- MARK CUBAN COST PLUS DRUG COMPANY (MCCPDC) INTENDS TO GENERATE A CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA PACKAGE SUITABLE FOR AN FDA ABBREVIATED NEW DRUG APPLICATION (ANDA).
- naics code
- 541715
- naics description
- RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- psc code
- AC12
- texas nigp code
- Not published
- value obligated
- 1393259.04
- Total / ceiling as published (not obligated)
- Not published
- pop start date
- 2026-04-13T05:00:00.000Z
- expiry date
- 2028-04-12T05:00:00.000Z
- place of performance state
- TX
- recipient location state
- TX
- set aside type
- SMALL BUSINESS SET ASIDE - TOTAL
- source as of
- 2026-05-08T05:00:00.000Z
- last synced
- 2026-11-10T06:00:00.000Z
- published
- true
- Source expiry field
- Period of performance current end date (USASpending)